Moneycontrol PRO

trends

Cipla revises growth forecast to about 20% after strong Q1

Drug major Cipla reported a strong set of earnings for first quarter of FY16. CNBC-TV18's Archana Shukla caught up with the company's MD and CEO Subhanu Saxena and asked him about the drivers for this sales momentum.

first published: Aug 17, 2015 10:59 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347